A158T (p.Ala158Thr) variant of BCL11B (B-cell lymphoma/leukemia 11B)
A158T (p.Ala158Thr) in BCL11B (B-cell lymphoma/leukemia 11B) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.43 / 1. The record also includes population frequency data and structural context.
A158T (p.Ala158Thr) variant details
- p.Ala158Thr
- TOPMed rs1337887157
- Missense
- Variant Prioritization Score for Impact Estimate 0.432
- REVEL 0.19
- CADD 24.20
- PolyPhen-2 0.96
- SIFT 0.19
- Population evidence available
- Structural context available